Novel Anticancer Agents and Targets: Recent Advances and Future Perspectives

被引:1
作者
Barot, Kuldipsinh P. [1 ]
Nikolova, Stoyanka [2 ]
Ivanov, Illiyan [2 ]
Ghate, Manjunath D. [1 ]
机构
[1] Nirma Univ, Inst Pharm, Dept Pharmaceut Chem, Ahmadabad 382481, Gujarat, India
[2] Paisij Hilendarski Univ Plovdiv, Fac Chem, Plovdiv 4000, Bulgaria
关键词
Cancer; novel anticancer agents; novel heterocyclic compounds; novel anticancer targets; chemogenomics; FARNESYL TRANSFERASE INHIBITORS; IN-VITRO; TOPOISOMERASE-I; BREAST-CANCER; ANTITUMOR BENZOTHIAZOLES; BIOLOGICAL EVALUATION; DRUG DISCOVERY; ANTIESTROGENIC PROPERTIES; CYTOTOXICITY EVALUATION; AROMATASE INHIBITORS;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An urgent need for the discovery of novel anticancer agents is required for the long term therapy of cancer. Large number of novel bio-active and potential anticancer agents are being used in clinical and pre-clinical trials. Although many heterocyclic compounds are already available commercially as anticancer agents, great efforts have been put to identify novel anticancer targets. This review provides an insight of the novel anticancer targets and molecules of the first and final stage of clinical and pre-clinical trials.
引用
收藏
页码:1239 / 1255
页数:17
相关论文
共 89 条
[1]  
Adams J, 1999, CANCER RES, V59, P2615
[2]   Isolated Coronary Artery Bypass Grafting in Obese Individuals - A Propensity Matched Analysis of Outcomes [J].
Alam, Mahboob ;
Siddiqui, Sahar ;
Lee, Vei-Vei ;
Elayda, McArthur A. ;
Nambi, Vijay ;
Yang, Eric Y. ;
Jneid, Hani M. ;
Wilson, James M. ;
Ballantyne, Christie M. ;
Virani, Salim S. .
CIRCULATION JOURNAL, 2011, 75 (06) :1378-1385
[3]   Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer [J].
Atalay, G ;
Cardoso, F ;
Awada, A ;
Piccart, MJ .
ANNALS OF ONCOLOGY, 2003, 14 (09) :1346-1363
[4]   Drug discovery from medicinal plants [J].
Balunas, MJ ;
Kinghorn, AD .
LIFE SCIENCES, 2005, 78 (05) :431-441
[5]   Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain [J].
Bannister, AJ ;
Zegerman, P ;
Partridge, JF ;
Miska, EA ;
Thomas, JO ;
Allshire, RC ;
Kouzarides, T .
NATURE, 2001, 410 (6824) :120-124
[6]   A ROUTE TO ARTIFICIAL GLYCOCONJUGATES AND OLIGOSACCHARIDES VIA ENZYMATICALLY RESOLVED GLYCALS - DRAMATIC EFFECTS OF THE HANDEDNESS OF THE SUGAR DOMAIN UPON THE PROPERTIES OF AN ANTHRACYCLINE DRUG [J].
BERKOWITZ, DB ;
DANISHEFSKY, SJ ;
SCHULTE, GK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (12) :4518-4529
[7]  
Bhat KPL, 2001, CANCER RES, V61, P7456
[8]  
Bhat KPL, 2001, CANCER RES, V61, P6137
[9]   Chemogenomics: Bridging a drug discovery gap [J].
Bleicher, KH .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (23) :2077-2084
[10]   Biomolecular Targets for Platinum Antitumor Drugs [J].
Bose, Rathindra N. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (02) :103-111